[1]
A. Shukla, G. Awasthi, and M. Nigam, “Discovery of Potential Multi-Target Therapeutics for Alzheimer’s Disease Through in Silico Drug Repurposing and Molecular Docking: Identification of Withaferin A and Sorafenib as Promising Candidates”, tajas, pp. 327–344, Jun. 2026.